Novo Nordisk
NVO
NVO
1,046 hedge funds and large institutions have $19.3B invested in Novo Nordisk in 2022 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 295 increasing their positions, 352 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,046
Holders Change
+142
Holders Change %
+15.71%
% of All Funds
16.88%
Holding in Top 10
46
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+64.29%
% of All Funds
0.74%
New
206
Increased
295
Reduced
352
Closed
49
Calls
$252M
Puts
$142M
Net Calls
+$109M
Net Calls Change
+$51M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$476M |
| 2 |
Morgan Stanley
New York
|
+$199M |
| 3 |
Millennium Management
New York
|
+$151M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$93.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$90.7M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$366M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$82.9M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$75.6M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$53.7M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$41.5M |
